Compositions and methods for differentiating rpe cells

HK40137514APending Publication Date: 2026-09-11STEMCELL TECHNOLOGIES CANADA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026126980
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-06
Filing Date
2026-08-03
Publication Date
2026-09-11

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present disclosure relates to applications of culturing retinal pigment epithelium (RPE) cells. The method comprises a) providing a population of PSC; b) exposing the population of PSC to a first culture environment comprising an extracellular matrix protein and an inhibitor of BMP signaling; c) culturing the population of PSC in the first culture environment for between about 0 to 60 hours; and d) deriving the population of cells fated for the retinal linage.
Need to check novelty before this filing date? Find Prior Art

Description

This disclosure relates to the use of culturing retinal pigment epithelial (RPE) cells. The method includes: a) providing a population of PSCs; b) exposing the PSC population to a first culture environment containing extracellular matrix proteins and a BMP signaling inhibitor; c) culturing the PSC population in the first culture environment for approximately 0 to 60 hours; and d) obtaining a cell population destined for the retinal lineage. Abstract

Claims

CLAIMS:1) A method of differentiating a population of cells fated for the retinal lineage, the method comprising: a) providing a population of pluripotent stem cells (PSC); b) exposing the population of PSC to a first culture environment comprising an extracellular matrix protein and an inhibitor of bone morphogenetic protein (BMP) signaling; c) culturing the population of PSC in the first culture environment for between about Oto 60 hours; and d) deriving the population of cells fated for the retinal linage.2) The method of claim 1, wherein the first culture environment is free of one or both of i) a direct wnt signaling antagonist, and ii) an agonist of activin signaling.3) The method of claim 1 or 2, wherein the extracellular matrix protein is coated on a culture surface, and the extracellular matrix protein is vitronectin, laminin, fibronectin, collagen, or a mixture comprising more than one of the foregoing.4) The method of any one of claims 1 to 3, wherein a concentration of the inhibitor of BMP signaling is about 100 nM or lower.5) The method of any one of claims 1 to 4, wherein the inhibitor of BMP signaling is comprised in a first cell culture medium.6) The method of any one of claims 1 to 5 further comprising: e) exposing the population of cells fated for the retinal lineage to a second culture environment; f) culturing the population of cells for between about 0 to 60 hours; and g) deriving a population of eye field progenitors.7) The method of claim 6, wherein the second culture environment comprises the extracellular matrix protein and a second cell culture medium.8) The method of claim 7, wherein the second cell culture medium comprises a basal medium and one or more of insulin-like growth factor (IGF) and an agonist of fibroblast growth factor (FGF) signaling.9) The method of any one of claims 6 to 8, further comprising: h) exposing the population of eye field progenitors to a third culture environment; i) culturing the population of eye field progenitors for between about 2 to 5 days; and j) deriving a population of optic vessel progenitors.10) The method of claim 9, wherein the third culture environment comprises the extracellular matrix protein and a third cell culture medium.11) The method of claim 10, wherein the third cell culture medium comprises a basal medium and one or more of IGF and an agonist of activin signaling.12) The method of any one of claims 9 to 11, wherein an optic vessel progenitor is bipotent for retinal pigment epithelium or neural retina.13) The method of any one of claims 9 to 12, further comprising: k) exposing the population of optic vessel progenitors to a fourth culture environment; l) culturing the population of optic vessel progenitors for between about 5 to 10 days; and m) deriving a population of immature retinal pigment epithelial cells.14) The method of claim 13, wherein the third culture environment comprises the extracellular matrix protein and a fourth cell culture medium.15) The method of claim 14, wherein the fourth cell culture medium comprises a basal medium and one or more of an agonist of activin signaling, an agonist of wnt signaling, and an antagonist of FGF signaling.16) The method of any one of claims 13 to 15, further comprising dissociating the population of immature retinal pigment epithelial cells and replating the dissociated cells to enrich for immature retinal pigment epithelial cells.17) The method of claim 16, wherein the dissociated population of immature retinal pigment epithelial cells are not enriched through manual dissection, particle-based enrichment, or ligand- mediated enrichment.18) The method of any one of claim 13 to 17, wherein about 50% or more of the population of immature retinal pigment epithelial cells express PMEL17.19) The method of any one of claims 13 to 18, further comprising maturing the population of immature retinal pigment epithelial cells for between about 1 to 5 weeks.20) The method of claim 19, wherein the population of immature retinal pigment epithelial cells are matured in contact with a maturation medium comprising a basal medium and at least a soluble source of iron.21) The method of claim 20, wherein the maturation medium further comprises one or more of a steroid hormone and a polyamine.22) The method of any one of claims 19 to 21, wherein about 80% or more of the matured retinal pigment epithelial cells (RPE) express RPE65.23) The method of any one of claims 1 to 22, wherein one or more of the first culture environment, the second culture environment, the third culture environment, and the fourth culture environment is serum-free and / or animal component free.24) The method of any one of claims 6 to 23, wherein one or more of the second culture medium, the third culture medium, and the fourth culture medium lacks an exogenously added inhibitor of BMP signaling.25) The method of any one of claims 1 to 24, wherein one or more of the first culture medium, the second culture medium, the third culture medium, and the fourth culture medium lacks nicotinamide.26) The method of claim 1, wherein the population of PSC are cultured under non-adherent conditions to produce three-dimensional retinal organoids.27) The method of claim 26, wherein the population of PSC are seeded into a microwell device.